查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球C反应蛋白检测市场规模、份额和行业趋势分析报告：用途、按检测类型、按最终用户、按地区、前景和预测，2023-2030年
市场调查报告书
商品编码
1353114

全球C反应蛋白检测市场规模、份额和行业趋势分析报告：用途、按检测类型、按最终用户、按地区、前景和预测，2023-2030年

Global C-reactive Protein Testing Market Size, Share & Industry Trends Analysis Report By Application, By Assay Type, By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 268 Pages | 订单完成后即时交付

价格

C反应蛋白检测市场规模预计到2030年将达35亿美元，预测期内年复合成长率年增长率为2.8%。

此外，COVID-19 的爆发也支持了 C 反应蛋白检测市场。世界各地的许多诊所和医院都进行了重组，以增加医院收治新冠肺炎 (COVID-19) 患者的能力。 C反应蛋白（CRP）作为一项重要指标被观察到在重症COVID-19患者中显着升高。由于发炎消退时 CRP 浓度会降低，因此它被认为是评估 COVID-19 和肺部病变严重程度的有价值的标记。因此，CRP 检测在 COVID-19 大流行期间激增，显着提高了市场成长率。

但CRP是发炎的综合指标。因此，该测试不足以准确诊断所有疾病。因此，它不是一个独立的诊断测试，这一事实可能会阻碍该市场的成长。磁振造影(MRI)、电脑断层扫描 (CT) 和超音波影像检查可以帮助可视化发炎组织，并帮助诊断关节炎、感染疾病和发炎性肠道疾病。由于有许多可用的替代疾病诊断技术，市场扩张可能会受到消费者受欢迎程度的限制。

应用前景

依用途，市场分为糖尿病、类风湿性关节炎、心血管疾病、发炎性肠道疾病等。预计到 2022 年，类类风湿性关节炎领域将在市场中占据显着的收入份额。 CRP 水平升高以及其他实验室检查和临床评估可以帮助诊断类风湿性关节炎。随着时间的推移，CRP 水平下降通常表示治疗方法有效抑制了 RA 相关发炎。

检测类型展望

依分析类型，市场分为酵素连结免疫吸附检测法（ELISA）、化学发光免疫检测（CLIA）、检测法等。 2022 年，酵素结合免疫吸附检测法(ELISA) 领域在市场中获得了巨大的收入份额。以 ELISA检测样本中 CRP 的准确浓度，提供定量资料。这样可以准确监测随时间的变化，并帮助医疗保健专业人员评估疾病活动和治疗反应。由于 ELISA 方法可以设计为对 CRP 具有高度特异性，因此测试结果不太可能受到与血液中其他物质的交叉反应的影响。

最终用户前景

依最终用户划分，市场分为医院/诊所、诊断实验室等。诊断实验室领域将在 2022 年出现显着的市场成长率。诊断实验室对于兽医疼痛管理至关重要，因为它们为准确诊断、治疗计划和持续监测动物疼痛提供了基础。它们在改善动物生活品质和福利方面的作用怎么强调都不为过，它们对兽医和宠物饲主来说都是宝贵的资源。

区域展望

从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022年，北美地区的市占率最高。即时检测的便利性和速度是该地区的成长趋势。 POCT 快速检测 CRP 有助于及时诊断和治疗。北美市场预计将受到技术进步的推动，这些技术进步提高了 CRP 测试的准确性、有效性和可负担性。在预测期内，北美市场预计将受到发炎疾病日益患病、不健康的生活方式以及用于早期检测发炎疾病的新检测套组和解决方案的开拓的推动。

目录

第1章市场范围和调查方法

  • 市场定义
  • 目的
  • 市场范围
  • 分割
  • 调查方法

第2章市场概况

  • 主要亮点

第3章市场概况

  • 介绍
    • 概述
      • 市场结构和情景
  • 影响市场的主要要素
    • 市场促进因素
    • 市场抑制因素
  • 波特五力分析

第4章全球 C 反应蛋白检测市场：依用途

  • 全球心血管疾病市场：按地区
  • 全球发炎性肠道疾病市场：按地区
  • 全球类类风湿性关节炎市场：按地区
  • 全球糖尿病市场：按地区
  • 世界其他市场：按地区

第5章全球 C 反应蛋白检测市场：依检测类型

  • 全球免疫比浊法市场：按地区
  • 全球酵素免疫分析法测定 (ELISA) 市场：按地区
  • 全球化学免疫检测(CLIA) 市场：按地区
  • 世界其他市场：按地区

第6章全球 C 反应蛋白测试市场：依最终用户分类

  • 全球医院和诊所市场：按地区
  • 全球诊断实验室市场：按地区
  • 世界其他市场：按地区

第7章全球C反应蛋白检测市场：按地区

  • 北美洲
    • 北美市场：按国家划分
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲市场：依国家分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 义大利
      • 其他欧洲国家地区
  • 亚太地区
    • 亚太市场：依国家分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉丁美洲/中东/非洲
    • 拉丁美洲/中东/非洲市场：依国家分类
      • 巴西
      • 阿根廷
      • 阿拉伯聯合大公国
      • 沙乌地阿拉伯
      • 南非
      • 奈及利亚
      • 其他拉丁美洲/中东/非洲地区

第8章公司简介

  • Danaher Corporation
  • F Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • Horiba Ltd
  • Randox Laboratories Limited
  • Zoetis, Inc
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Merck KGaA

第9章赢得C反应蛋白检测市场的必备条件

The Global C-Reactive Protein Testing Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 2.8% CAGR during the forecast period.

Chronic conditions like cardiovascular conditions are associated with high C-reactive protein levels. Therefore, Cardiovascular Disease segment would capture more than 56% share of the market by 2030. The primary factor advancing the expansion of the segment is the rise in the prevalence of CVDs. CRP is a critical marker for identifying CVD by determining the probability of atherosclerosis. Patients with CVDs often have elevated CRP levels, and assays may identify even the lowest amounts of CRP. As a result, the use of CRP testing for the early diagnosis of cardiovascular disorders has dramatically increased, which has caused this segment's revenue to grow throughout the projection period. Some of the Factors impacting the market are increase prevalence of inflammatory diseases, increasing demand for point-of-care testing, and alternative disease-testing techniques are accessible.

This market is projected to expand as inflammatory diseases grow more widespread. The liver produces CRP, an acute-phase protein, in response to tissue damage, infection, or inflammation. The existence of inflammation in the body, which is associated with various illnesses such as cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and several types of cancers, may be indicated by elevated levels of CRP in the blood. Overall, the prevalence of inflammatory diseases is on the rise, and CRP testing methods have advanced in technology, which is expected to propel the market. Moreover, POCT is a medical examination carried out near the patient rather than in a centralized laboratory and offers immediate results. POCT for CRP makes testing fast and simple in primary care settings, ERs, and other point-of-care settings, which is especially beneficial for patients who need diagnosis and treatment immediately. This market is predicted to be boosted by increased demand for POCT since it offers a cost-effective and accessible alternative for laboratory testing, which may benefit patients' outcomes and lower healthcare expenditures.

Additionally, The COVID-19 outbreak assisted the market for C-reactive protein testing. In order to boost hospital capacity for patients diagnosed with COVID-19, many clinics and hospitals worldwide were restructured. C-reactive protein (CRP) was observed as a crucial measure that significantly rose among people with severe COVID-19. It was considered a valuable marker for assessing the severity of the disease and lung lesions because its concentration decreases when the inflammatory stages end and the patient heals. As a result, CRP testing surged during the COVID-19 pandemic, considerably increasing market growth.

However, C-reactive protein is a comprehensive indicator of inflammation. As a result, this test is inadequate for accurately diagnosing any illness. Therefore, the fact that it is not a self-sufficient diagnostic test could prevent this market from growing. Imaging studies like magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound can visualize inflamed tissues and help diagnose conditions such as arthritis, infections, and inflammatory bowel disease. As there are numerous alternative disease diagnostic technologies accessible, the market's expansion might be restricted by their popularity among consumers.

Application Outlook

Based on application, the market is fragmented into diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others. The rheumatoid arthritis segment projected a prominent revenue share in the market in 2022. Elevated CRP levels, along with other laboratory tests and clinical evaluations, can aid in diagnosing rheumatoid arthritis, even though no single test can confirm the diagnosis. CRP level reduction over time often indicates that a treatment technique effectively controls RA-related inflammation.

Assay Type Outlook

By assay type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), immunoturbidimetric assays, and others. The enzyme-linked immunosorbent assay (ELISA) segment acquired a substantial revenue share in the market in 2022. The precise concentration of CRP in a sample is measured by ELISA, which produces quantitative data. This enables precise monitoring of changes over time and aids in evaluating disease activity and treatment response by healthcare professionals. Since ELISA assays can be designed to be very specific to CRP, there is a low probability that the test results will be affected by any cross-reactivity with other substances in the blood.

End User Outlook

based on end user, the market is divided into hospitals & clinics, diagnostic laboratories, and others. The diagnostics laboratories segment witnessed a remarkable growth rate in the market in 2022. Diagnostic laboratories are essential in veterinary pain management as they provide the foundation for accurate diagnosis, treatment planning, and ongoing monitoring of pain in animals. Their role in improving the quality of life and welfare of animals cannot be overstated, and they are a valuable resource for veterinarians and pet owners alike.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The convenience and rapidity of point-of-care testing are making it a growing trend in the region. Rapid results of POCT for CRP testing can help with rapid diagnosis and therapy. The market in North America is anticipated to be driven by technological advancements that have improved CRP testing's accuracy, efficacy, and affordability. During the forecast period, it is predicted that the market in North America will be driven by the growth in the prevalence of inflammatory diseases unhealthy lifestyles, and the development of new testing kits and solutions for early detection of inflammatory ailments.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Danaher Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Randox Laboratories Limited, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Horiba, Ltd., Merck KGaA, and Zoetis, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis
  • Diabetes
  • Others

By Assay Type

  • Immunoturbidimetric Assays
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Limited
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • Horiba, Ltd.
  • Merck KGaA
  • Zoetis, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global C-reactive Protein Testing Market, by Application
    • 1.4.2 Global C-reactive Protein Testing Market, by Assay Type
    • 1.4.3 Global C-reactive Protein Testing Market, by End User
    • 1.4.4 Global C-reactive Protein Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Global C-reactive Protein Testing Market by Application

  • 4.1 Global Cardiovascular Disease Market by Region
  • 4.2 Global Inflammatory Bowel Disease Market by Region
  • 4.3 Global Rheumatoid Arthritis Market by Region
  • 4.4 Global Diabetes Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global C-reactive Protein Testing Market by Assay Type

  • 5.1 Global Immunoturbidimetric Assays Market by Region
  • 5.2 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region
  • 5.3 Global Chemiluminescence Immunoassay (CLIA) Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global C-reactive Protein Testing Market by End User

  • 6.1 Global Hospitals & Clinics Market by Region
  • 6.2 Global Diagnostic Laboratories Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global C-reactive Protein Testing Market by Region

  • 7.1 North America C-reactive Protein Testing Market
    • 7.1.1 North America C-reactive Protein Testing Market by Application
      • 7.1.1.1 North America Cardiovascular Disease Market by Country
      • 7.1.1.2 North America Inflammatory Bowel Disease Market by Country
      • 7.1.1.3 North America Rheumatoid Arthritis Market by Country
      • 7.1.1.4 North America Diabetes Market by Country
      • 7.1.1.5 North America Others Market by Country
    • 7.1.2 North America C-reactive Protein Testing Market by Assay Type
      • 7.1.2.1 North America Immunoturbidimetric Assays Market by Country
      • 7.1.2.2 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.1.2.3 North America Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.1.2.4 North America Others Market by Country
    • 7.1.3 North America C-reactive Protein Testing Market by End User
      • 7.1.3.1 North America Hospitals & Clinics Market by Country
      • 7.1.3.2 North America Diagnostic Laboratories Market by Country
      • 7.1.3.3 North America Others Market by Country
    • 7.1.4 North America C-reactive Protein Testing Market by Country
      • 7.1.4.1 US C-reactive Protein Testing Market
        • 7.1.4.1.1 US C-reactive Protein Testing Market by Application
        • 7.1.4.1.2 US C-reactive Protein Testing Market by Assay Type
        • 7.1.4.1.3 US C-reactive Protein Testing Market by End User
      • 7.1.4.2 Canada C-reactive Protein Testing Market
        • 7.1.4.2.1 Canada C-reactive Protein Testing Market by Application
        • 7.1.4.2.2 Canada C-reactive Protein Testing Market by Assay Type
        • 7.1.4.2.3 Canada C-reactive Protein Testing Market by End User
      • 7.1.4.3 Mexico C-reactive Protein Testing Market
        • 7.1.4.3.1 Mexico C-reactive Protein Testing Market by Application
        • 7.1.4.3.2 Mexico C-reactive Protein Testing Market by Assay Type
        • 7.1.4.3.3 Mexico C-reactive Protein Testing Market by End User
      • 7.1.4.4 Rest of North America C-reactive Protein Testing Market
        • 7.1.4.4.1 Rest of North America C-reactive Protein Testing Market by Application
        • 7.1.4.4.2 Rest of North America C-reactive Protein Testing Market by Assay Type
        • 7.1.4.4.3 Rest of North America C-reactive Protein Testing Market by End User
  • 7.2 Europe C-reactive Protein Testing Market
    • 7.2.1 Europe C-reactive Protein Testing Market by Application
      • 7.2.1.1 Europe Cardiovascular Disease Market by Country
      • 7.2.1.2 Europe Inflammatory Bowel Disease Market by Country
      • 7.2.1.3 Europe Rheumatoid Arthritis Market by Country
      • 7.2.1.4 Europe Diabetes Market by Country
      • 7.2.1.5 Europe Others Market by Country
    • 7.2.2 Europe C-reactive Protein Testing Market by Assay Type
      • 7.2.2.1 Europe Immunoturbidimetric Assays Market by Country
      • 7.2.2.2 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.2.2.3 Europe Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.2.2.4 Europe Others Market by Country
    • 7.2.3 Europe C-reactive Protein Testing Market by End User
      • 7.2.3.1 Europe Hospitals & Clinics Market by Country
      • 7.2.3.2 Europe Diagnostic Laboratories Market by Country
      • 7.2.3.3 Europe Others Market by Country
    • 7.2.4 Europe C-reactive Protein Testing Market by Country
      • 7.2.4.1 Germany C-reactive Protein Testing Market
        • 7.2.4.1.1 Germany C-reactive Protein Testing Market by Application
        • 7.2.4.1.2 Germany C-reactive Protein Testing Market by Assay Type
        • 7.2.4.1.3 Germany C-reactive Protein Testing Market by End User
      • 7.2.4.2 UK C-reactive Protein Testing Market
        • 7.2.4.2.1 UK C-reactive Protein Testing Market by Application
        • 7.2.4.2.2 UK C-reactive Protein Testing Market by Assay Type
        • 7.2.4.2.3 UK C-reactive Protein Testing Market by End User
      • 7.2.4.3 France C-reactive Protein Testing Market
        • 7.2.4.3.1 France C-reactive Protein Testing Market by Application
        • 7.2.4.3.2 France C-reactive Protein Testing Market by Assay Type
        • 7.2.4.3.3 France C-reactive Protein Testing Market by End User
      • 7.2.4.4 Russia C-reactive Protein Testing Market
        • 7.2.4.4.1 Russia C-reactive Protein Testing Market by Application
        • 7.2.4.4.2 Russia C-reactive Protein Testing Market by Assay Type
        • 7.2.4.4.3 Russia C-reactive Protein Testing Market by End User
      • 7.2.4.5 Spain C-reactive Protein Testing Market
        • 7.2.4.5.1 Spain C-reactive Protein Testing Market by Application
        • 7.2.4.5.2 Spain C-reactive Protein Testing Market by Assay Type
        • 7.2.4.5.3 Spain C-reactive Protein Testing Market by End User
      • 7.2.4.6 Italy C-reactive Protein Testing Market
        • 7.2.4.6.1 Italy C-reactive Protein Testing Market by Application
        • 7.2.4.6.2 Italy C-reactive Protein Testing Market by Assay Type
        • 7.2.4.6.3 Italy C-reactive Protein Testing Market by End User
      • 7.2.4.7 Rest of Europe C-reactive Protein Testing Market
        • 7.2.4.7.1 Rest of Europe C-reactive Protein Testing Market by Application
        • 7.2.4.7.2 Rest of Europe C-reactive Protein Testing Market by Assay Type
        • 7.2.4.7.3 Rest of Europe C-reactive Protein Testing Market by End User
  • 7.3 Asia Pacific C-reactive Protein Testing Market
    • 7.3.1 Asia Pacific C-reactive Protein Testing Market by Application
      • 7.3.1.1 Asia Pacific Cardiovascular Disease Market by Country
      • 7.3.1.2 Asia Pacific Inflammatory Bowel Disease Market by Country
      • 7.3.1.3 Asia Pacific Rheumatoid Arthritis Market by Country
      • 7.3.1.4 Asia Pacific Diabetes Market by Country
      • 7.3.1.5 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific C-reactive Protein Testing Market by Assay Type
      • 7.3.2.1 Asia Pacific Immunoturbidimetric Assays Market by Country
      • 7.3.2.2 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.3.2.3 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.3.2.4 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific C-reactive Protein Testing Market by End User
      • 7.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
      • 7.3.3.2 Asia Pacific Diagnostic Laboratories Market by Country
      • 7.3.3.3 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific C-reactive Protein Testing Market by Country
      • 7.3.4.1 China C-reactive Protein Testing Market
        • 7.3.4.1.1 China C-reactive Protein Testing Market by Application
        • 7.3.4.1.2 China C-reactive Protein Testing Market by Assay Type
        • 7.3.4.1.3 China C-reactive Protein Testing Market by End User
      • 7.3.4.2 Japan C-reactive Protein Testing Market
        • 7.3.4.2.1 Japan C-reactive Protein Testing Market by Application
        • 7.3.4.2.2 Japan C-reactive Protein Testing Market by Assay Type
        • 7.3.4.2.3 Japan C-reactive Protein Testing Market by End User
      • 7.3.4.3 India C-reactive Protein Testing Market
        • 7.3.4.3.1 India C-reactive Protein Testing Market by Application
        • 7.3.4.3.2 India C-reactive Protein Testing Market by Assay Type
        • 7.3.4.3.3 India C-reactive Protein Testing Market by End User
      • 7.3.4.4 South Korea C-reactive Protein Testing Market
        • 7.3.4.4.1 South Korea C-reactive Protein Testing Market by Application
        • 7.3.4.4.2 South Korea C-reactive Protein Testing Market by Assay Type
        • 7.3.4.4.3 South Korea C-reactive Protein Testing Market by End User
      • 7.3.4.5 Singapore C-reactive Protein Testing Market
        • 7.3.4.5.1 Singapore C-reactive Protein Testing Market by Application
        • 7.3.4.5.2 Singapore C-reactive Protein Testing Market by Assay Type
        • 7.3.4.5.3 Singapore C-reactive Protein Testing Market by End User
      • 7.3.4.6 Malaysia C-reactive Protein Testing Market
        • 7.3.4.6.1 Malaysia C-reactive Protein Testing Market by Application
        • 7.3.4.6.2 Malaysia C-reactive Protein Testing Market by Assay Type
        • 7.3.4.6.3 Malaysia C-reactive Protein Testing Market by End User
      • 7.3.4.7 Rest of Asia Pacific C-reactive Protein Testing Market
        • 7.3.4.7.1 Rest of Asia Pacific C-reactive Protein Testing Market by Application
        • 7.3.4.7.2 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type
        • 7.3.4.7.3 Rest of Asia Pacific C-reactive Protein Testing Market by End User
  • 7.4 LAMEA C-reactive Protein Testing Market
    • 7.4.1 LAMEA C-reactive Protein Testing Market by Application
      • 7.4.1.1 LAMEA Cardiovascular Disease Market by Country
      • 7.4.1.2 LAMEA Inflammatory Bowel Disease Market by Country
      • 7.4.1.3 LAMEA Rheumatoid Arthritis Market by Country
      • 7.4.1.4 LAMEA Diabetes Market by Country
      • 7.4.1.5 LAMEA Others Market by Country
    • 7.4.2 LAMEA C-reactive Protein Testing Market by Assay Type
      • 7.4.2.1 LAMEA Immunoturbidimetric Assays Market by Country
      • 7.4.2.2 LAMEA Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.4.2.3 LAMEA Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.4.2.4 LAMEA Others Market by Country
    • 7.4.3 LAMEA C-reactive Protein Testing Market by End User
      • 7.4.3.1 LAMEA Hospitals & Clinics Market by Country
      • 7.4.3.2 LAMEA Diagnostic Laboratories Market by Country
      • 7.4.3.3 LAMEA Others Market by Country
    • 7.4.4 LAMEA C-reactive Protein Testing Market by Country
      • 7.4.4.1 Brazil C-reactive Protein Testing Market
        • 7.4.4.1.1 Brazil C-reactive Protein Testing Market by Application
        • 7.4.4.1.2 Brazil C-reactive Protein Testing Market by Assay Type
        • 7.4.4.1.3 Brazil C-reactive Protein Testing Market by End User
      • 7.4.4.2 Argentina C-reactive Protein Testing Market
        • 7.4.4.2.1 Argentina C-reactive Protein Testing Market by Application
        • 7.4.4.2.2 Argentina C-reactive Protein Testing Market by Assay Type
        • 7.4.4.2.3 Argentina C-reactive Protein Testing Market by End User
      • 7.4.4.3 UAE C-reactive Protein Testing Market
        • 7.4.4.3.1 UAE C-reactive Protein Testing Market by Application
        • 7.4.4.3.2 UAE C-reactive Protein Testing Market by Assay Type
        • 7.4.4.3.3 UAE C-reactive Protein Testing Market by End User
      • 7.4.4.4 Saudi Arabia C-reactive Protein Testing Market
        • 7.4.4.4.1 Saudi Arabia C-reactive Protein Testing Market by Application
        • 7.4.4.4.2 Saudi Arabia C-reactive Protein Testing Market by Assay Type
        • 7.4.4.4.3 Saudi Arabia C-reactive Protein Testing Market by End User
      • 7.4.4.5 South Africa C-reactive Protein Testing Market
        • 7.4.4.5.1 South Africa C-reactive Protein Testing Market by Application
        • 7.4.4.5.2 South Africa C-reactive Protein Testing Market by Assay Type
        • 7.4.4.5.3 South Africa C-reactive Protein Testing Market by End User
      • 7.4.4.6 Nigeria C-reactive Protein Testing Market
        • 7.4.4.6.1 Nigeria C-reactive Protein Testing Market by Application
        • 7.4.4.6.2 Nigeria C-reactive Protein Testing Market by Assay Type
        • 7.4.4.6.3 Nigeria C-reactive Protein Testing Market by End User
      • 7.4.4.7 Rest of LAMEA C-reactive Protein Testing Market
        • 7.4.4.7.1 Rest of LAMEA C-reactive Protein Testing Market by Application
        • 7.4.4.7.2 Rest of LAMEA C-reactive Protein Testing Market by Assay Type
        • 7.4.4.7.3 Rest of LAMEA C-reactive Protein Testing Market by End User

Chapter 8. Company Profiles

  • 8.1 Danaher Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 SWOT Analysis
  • 8.4 Thermo Fisher Scientific, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 SWOT Analysis
  • 8.5 Horiba Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional & Segmental Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 Randox Laboratories Limited
    • 8.6.1 Company Overview
    • 8.6.2 SWOT Analysis
  • 8.7 Zoetis, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Quest Diagnostics Incorporated
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental Analysis
    • 8.8.4 SWOT Analysis
  • 8.9 Laboratory Corporation of America Holdings
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental Analysis
    • 8.9.4 SWOT Analysis
  • 8.10. Merck KGaA
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperative for C-Reactive Protein Testing Market

LIST OF TABLES

  • TABLE 1 Global C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 2 Global C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 3 Global C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 4 Global C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 5 Global Cardiovascular Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Cardiovascular Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Inflammatory Bowel Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Inflammatory Bowel Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Rheumatoid Arthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Rheumatoid Arthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Diabetes Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Diabetes Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 15 Global C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 16 Global C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 17 Global Immunoturbidimetric Assays Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Immunoturbidimetric Assays Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 26 Global C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 27 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 33 Global C-reactive Protein Testing Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global C-reactive Protein Testing Market by Region, 2023 - 2030, USD Million
  • TABLE 35 North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 36 North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 37 North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 38 North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 39 North America Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 50 North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 51 North America Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 55 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 60 North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 61 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 62 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 63 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 67 North America C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 68 North America C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 69 US C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 70 US C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 71 US C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 72 US C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 73 US C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 74 US C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 75 US C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 76 US C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 77 Canada C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 78 Canada C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 79 Canada C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Canada C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Canada C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 82 Canada C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 83 Canada C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 84 Canada C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 85 Mexico C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 88 Mexico C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 89 Mexico C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 90 Mexico C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 91 Mexico C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Mexico C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 101 Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 102 Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 103 Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 104 Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 105 Europe Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 116 Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 126 Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 127 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 133 Europe C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 134 Europe C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 135 Germany C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 136 Germany C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 137 Germany C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 138 Germany C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 139 Germany C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 140 Germany C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 141 Germany C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 142 Germany C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 143 UK C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 144 UK C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 145 UK C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 146 UK C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 147 UK C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 148 UK C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 149 UK C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 150 UK C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 151 France C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 152 France C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 153 France C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 154 France C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 155 France C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 156 France C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 157 France C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 158 France C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 159 Russia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 160 Russia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 161 Russia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 162 Russia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 163 Russia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 164 Russia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 165 Russia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 166 Russia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 167 Spain C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 168 Spain C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 169 Spain C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 170 Spain C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 171 Spain C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 172 Spain C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 173 Spain C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 174 Spain C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 175 Italy C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 176 Italy C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 177 Italy C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 178 Italy C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 179 Italy C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 180 Italy C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 181 Italy C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 182 Italy C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 183 Rest of Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 184 Rest of Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 185 Rest of Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 186 Rest of Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 187 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 188 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 189 Rest of Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 190 Rest of Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 225 China C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 226 China C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 227 China C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 228 China C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 229 China C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 230 China C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 231 China C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 232 China C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 233 Japan C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 234 Japan C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 235 Japan C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 236 Japan C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 237 Japan C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 238 Japan C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 239 Japan C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 240 Japan C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 241 India C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 242 India C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 243 India C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 244 India C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 245 India C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 246 India C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 247 India C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 248 India C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 249 South Korea C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 250 South Korea C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 251 South Korea C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 252 South Korea C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 253 South Korea C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 254 South Korea C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 255 South Korea C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 256 South Korea C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 257 Singapore C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 258 Singapore C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 259 Singapore C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 260 Singapore C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 261 Singapore C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 262 Singapore C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 263 Singapore C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 264 Singapore C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 265 Malaysia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 266 Malaysia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 267 Malaysia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 268 Malaysia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 269 Malaysia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 270 Malaysia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 271 Malaysia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 272 Malaysia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 273 Rest of Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 274 Rest of Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 275 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 276 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 277 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 278 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 279 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 280 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million